XINMED SDN. BHD.

XINMED SDN. BHD. specializes in single-use electrocardiographic lead sets. These devices are designed for temporary attachment to patients during cardiac monitoring or diagnostic procedures, enabling the transmission of heart signals to an ECG machine for accurate recording. The focus is on disposable lead sets, which are critical for maintaining hygiene and reliability in clinical settings.

XINMED SDN. BHD. is based in the United States. Since the company’s devices are regulated by the FDA, their classification and compliance requirements align with U.S. medical device regulations. The location ensures adherence to FDA-specific processes, including UDI listing and Class II classification for their electrocardiographic lead sets.

XINMED SDN. BHD.’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry is essential for tracking and identifying medical devices in the U.S., ensuring transparency in supply chains and compliance with regulatory requirements. The UDI listing helps healthcare providers and authorities verify the device’s identity and compliance status.

XINMED SDN. BHD.’s electrocardiographic lead sets fall under FDA Class II classification. This classification is assigned based on the device’s risk level and intended use—Class II devices require special controls beyond general controls to ensure safety and effectiveness. The classification influences the regulatory pathway, including pre-market notifications (510(k)) and post-market surveillance requirements.